The functional significance of inhibition of hormonal secretion and growth factors, including the inhibition of IGF1 expression and serum level, was further explored as effective adjuvant therapy for tamoxifen treatment in breast cancer; however, later studies failed to support the idea of there being any beneficial effect of SST in combination with tamoxifen [201,202,203]. This evidence concerns the gene IGF1 and breast carcinoma.